Concourse Financial Group Securities’s Xenon Pharmaceuticals XENE Stock Holding History

Concourse Financial Group Securities’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,000	Closed	-$78.4K	–	2121
2024 Q4	$78.4K	Hold	2,000	–	–	﹤0.01%	1022
2024 Q3	$78.7K	Hold	2,000	–	–	﹤0.01%	1023
2024 Q2	$78K	Hold	2,000	–	–	﹤0.01%	1011
2024 Q1	$86.1K	Hold	2,000	–	–	0.01%	972
2023 Q4	$92.1K	Hold	2,000	–	–	0.01%	918
2023 Q3	$68.3K	Hold	2,000	–	–	0.01%	961
2023 Q2	$77K	Hold	2,000	–	–	0.01%	934
2023 Q1	$71.6K	Hold	2,000	–	–	0.01%	969
2022 Q4	$78.9K	Hold	2,000	–	–	0.01%	911
2022 Q3	$72K	Hold	2,000	–	–	0.01%	837
2022 Q2	$61K	Hold	2,000	–	–	0.01%	1008
2022 Q1	$61K	Hold	2,000	–	–	﹤0.01%	1073
2021 Q4	$62K	Hold	2,000	–	–	﹤0.01%	1201
2021 Q3	$31K	Hold	2,000	–	–	﹤0.01%	1515
2021 Q2	$37K	Hold	2,000	–	–	﹤0.01%	1432
2021 Q1	$36K	Hold	2,000	–	–	﹤0.01%	1359
2020 Q4	$31K	Hold	2,000	–	–	﹤0.01%	1316
2020 Q3	$22K	Hold	2,000	–	–	﹤0.01%	1338
2020 Q2	$25K	Hold	2,000	–	–	﹤0.01%	1226
2020 Q1	$23K	Hold	2,000	–	–	﹤0.01%	1193
2019 Q4	$26K	Buy	2,000 +1,000	+100%	+$10.5K	﹤0.01%	1180
2019 Q3	$9K	Sell	1,000 -1,000	-50%	-$9.46K	﹤0.01%	1189
2019 Q2	$20K	Buy	2,000 +1,000	+100%	+$9.57K	﹤0.01%	1255
2019 Q1	$10K	Buy	+1,000	New	+$8.48K	﹤0.01%	1525

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Concourse Financial Group Securities's XENE Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Xenon Pharmaceuticals (XENE) in Q1 2025, closing a stake of 2,000 shares — an estimated $78.4K sold.

Concourse Financial Group Securities first reported a position in XENE in Q1 2019 and held it in 24 quarters. The position peaked at $92.1K in Q4 2023. 206 funds tracked by Wall St. Rank hold XENE as of Q1 2025.

Concourse Financial Group Securities reported no remaining Xenon Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Concourse Financial Group Securities sold 2,000 Xenon Pharmaceuticals shares in Q1 2025, an estimated $78.4K.
Concourse Financial Group Securities first reported a position in Xenon Pharmaceuticals in Q1 2019 and held it in 24 quarters.
Concourse Financial Group Securities's Xenon Pharmaceuticals position peaked at $92.1K in Q4 2023.
206 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.